Legal Representation
Attorney
Ian J. Block
USPTO Deadlines
Application History
13 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 3, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 3, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 28, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 30, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 28, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 28, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 28, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 27, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 27, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 27, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 18, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 30, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 3, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Protein molecules for scientific, laboratory and medical research use; Diagnostic reagents for scientific or research use; Chemicals for use in biotherapeutics and therapeutics product development and manufacturing processes, namely, chemicals for use in biotechnological product development; Biochemicals, namely, polypeptide encoding nucleic acids for laboratory research use; Monoclonal antibodies, antibody-based constructs, multispecific antibodies, antibody fragments, single-domain antibodies, engineered antibody formats, and antibody derivatives for scientific and medical laboratory research use
Class 042
Research, development and consultation services in the fields of biotechnology, immunology, monoclonal antibodies, antibody-based constructs, multispecific antibodies, antibody fragments, single-domain antibodies, engineered antibody formats, antibody derivatives, vaccines, medicine, biotherapeutics, and therapeutics, namely, scientific research and development in the field of protein therapeutics, and conducting scientific research and development in the field of monoclonal antibodies, antibody-based constructs, multispecific antibodies, antibody fragments, single-domain antibodies, engineered antibody formats, and antibody derivatives for others; Genetic engineering services utilizing a collection of genetic technologies for the rapid production of human antibodies, human antibody fragments, and other proteins comprising such antibodies and fragments, namely, conducting genetic engineering for scientific research purposes for others, conducting testing, inspection, research, and development of protein therapeutic preparations for others; Scientific and medical research for use in antibody sequence humanization and optimization via deep mutational scanning (DMS); Conducting scientific medical and genetic research for others
Class 045
Licensing of intellectual property to others in the fields of protein therapeutics, monoclonal antibodies, antibody-based constructs, multispecific antibodies, antibody fragments, single-domain antibodies, engineered antibody formats, and antibody derivatives
Additional Information
Pseudo Mark
MAB FORGE
Classification
International Classes
001
042
045